Condition
Painful Neuropathy
Total Trials
6
Recruiting
0
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Active Not Recruiting1
Terminated1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07163000Active Not Recruiting
Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)
NCT02758197Not ApplicableCompleted
Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain
NCT02125006Not ApplicableCompleted
The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain
NCT01992562Phase 4Withdrawn
Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy
NCT01667029Phase 2TerminatedPrimary
Study of Sulfasalazine in Treating Painful Neuropathy
NCT01363284Not ApplicableCompleted
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients
Showing all 6 trials